ZyVersa Therapeutics Stock Forward View - Accumulation Distribution
| ZVSA Stock | 0.17 0.01 6.25% |
ZyVersa Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ZyVersa Therapeutics stock prices and determine the direction of ZyVersa Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of ZyVersa Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, The value of RSI of ZyVersa Therapeutics' share price is at 51. This usually means that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling ZyVersa Therapeutics, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
Using ZyVersa Therapeutics hype-based prediction, you can estimate the value of ZyVersa Therapeutics from the perspective of ZyVersa Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
ZyVersa Therapeutics after-hype prediction price | USD 0.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ZyVersa Therapeutics to cross-verify your projections. For information on how to trade ZyVersa Stock refer to our How to Trade ZyVersa Stock guide.ZyVersa Therapeutics Additional Predictive Modules
Most predictive techniques to examine ZyVersa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ZyVersa using various technical indicators. When you analyze ZyVersa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 336.82 | 0.0588 |
| Check ZyVersa Therapeutics Volatility | Backtest ZyVersa Therapeutics | Information Ratio |
ZyVersa Therapeutics Trading Date Momentum
| On February 03 2026 ZyVersa Therapeutics was traded for 0.17 at the closing time. The top price for the day was 0.17 and the lowest listed price was 0.16 . There was no trading activity during the period 0.0. Lack of trading volume on February 3, 2026 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 5.88% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare ZyVersa Therapeutics to competition |
Other Forecasting Options for ZyVersa Therapeutics
For every potential investor in ZyVersa, whether a beginner or expert, ZyVersa Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ZyVersa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ZyVersa. Basic forecasting techniques help filter out the noise by identifying ZyVersa Therapeutics' price trends.ZyVersa Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ZyVersa Therapeutics stock to make a market-neutral strategy. Peer analysis of ZyVersa Therapeutics could also be used in its relative valuation, which is a method of valuing ZyVersa Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ZyVersa Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how ZyVersa Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ZyVersa Therapeutics shares will generate the highest return on investment. By undertsting and applying ZyVersa Therapeutics stock market strength indicators, traders can identify ZyVersa Therapeutics entry and exit signals to maximize returns.
ZyVersa Therapeutics Risk Indicators
The analysis of ZyVersa Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ZyVersa Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zyversa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.71 | |||
| Semi Deviation | 5.44 | |||
| Standard Deviation | 10.96 | |||
| Variance | 120.1 | |||
| Downside Variance | 91.37 | |||
| Semi Variance | 29.64 | |||
| Expected Short fall | (12.42) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ZyVersa Therapeutics
The number of cover stories for ZyVersa Therapeutics depends on current market conditions and ZyVersa Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ZyVersa Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ZyVersa Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ZyVersa Therapeutics Short Properties
ZyVersa Therapeutics' future price predictability will typically decrease when ZyVersa Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ZyVersa Therapeutics often depends not only on the future outlook of the potential ZyVersa Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ZyVersa Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 1.5 M |
Check out Historical Fundamental Analysis of ZyVersa Therapeutics to cross-verify your projections. For information on how to trade ZyVersa Stock refer to our How to Trade ZyVersa Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ZyVersa Therapeutics. Anticipated expansion of ZyVersa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ZyVersa Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate ZyVersa Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating ZyVersa Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause ZyVersa Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between ZyVersa Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ZyVersa Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, ZyVersa Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.